| 1 |
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign:international guidelines for management of sepsis and septic shock 2021 [J].Intensive Care Med, 2021, 47(11): 1181-1247.
|
| 2 |
Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study [J].Lancet, 2020, 395(10219): 200-211.
|
| 3 |
Xie J, Wang H, Kang Y, et al. The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey [J].Crit Care Med, 2020,48(3): e209-e218.
|
| 4 |
Chambers DC, Carew AM, Lukowski SW, et al.Transcriptomics and single-cell RNA-sequencing [J].Respirology, 2019, 24(1): 29-36.
|
| 5 |
Conway EM, Mackman N, Warren RQ, et al. Understanding COVID-19-associated coagulopathy [J].Nat Rev Immunol, 2022, 22(10): 639-649.
|
| 6 |
Lin VTG, Yang ES.The pros and cons of incorporating transcriptomics in the age of precision oncology [J].J Natl Cancer Inst, 2019, 111(10):1016-1022.
|
| 7 |
Tsimberidou AM, Fountzilas E, Bleris L, et al.Transcriptomics and solid tumors: the next frontier in precision cancer medicine [J].Semi Cancer Biol, 2022, 84: 50-59.
|
| 8 |
Hugo W, Zaretsky JM, Sun L, et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma [J].Cell, 2016, 165(1): 35-44.
|
| 9 |
Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine [J].N Engl J Med, 2020,383(27): 2603-2615.
|
| 10 |
Miller RR, Lopansri BK, Burke JP, et al. Validation of a host response assay, SeptiCyte LAB, for discriminating sepsis from systemic inflammatory response syndrome in the ICU [J].Am J Respir Crit Care Med, 2018, 198(7): 903-913.
|
| 11 |
Kalantar KL, Neyton L, Abdelghany M, et al. Integrated host-microbe plasma metagenomics for sepsis diagnosis in a prospective cohort of critically ill adults [J].Nat Microbiol, 2022, 7(11): 1805-1816.
|
| 12 |
Zheng X, Leung KS, Wong MH, et al. Long non-coding RNA pairs to assist in diagnosing sepsis [J].BMC Genomics, 2021, 22(1): 275-288.
|
| 13 |
Sweeney TE, Wong HR, Khatri P.Robust classification of bacterial and viral infections via integrated host gene expression diagnostics [J].Sci Transl Med 2016,8(346): 346ra96.
|
| 14 |
Mayhew MB, Buturovic L, Luethy R, et al. A generalizable 29-mRNA neural-network classifier for acute bacterial and viral infections [J].Nat Commun, 2020, 11(1): 1177.
|
| 15 |
Bauer W, Kappert K, Galtung N, et al. A novel 29-messenger RNA host-response assay from whole blood accurately identifies bacterial and viral infections in patients presenting to the emergency department with suspected infections: a prospective observational study [J].Crit Care Med, 2021, 49(10): 1664-1673.
|
| 16 |
Ram-Mohan N, Rogers AJ, Blish CA, et al. Using a 29-mRNA host response classifier to detect bacterial coinfections and predict outcomes in COVID-19 patients presenting to the emergency department [J].Microbiol Spectr, 2022, 10(6): e02305-02322.
|
| 17 |
Pereverzeva L, Uhel F, Peters Sengers H, et al. Blood leukocyte transcriptomes in Gram-positive and Gram-negative communityacquired pneumonia [J].Eur Respir J, 2022, 59(3): 2101856.
|
| 18 |
Bhavani SV, Carey KA, Gilbert ER, et al. Identifying novel sepsis subphenotypes using temperature trajectories [J].Am J Respir Crit Care Med, 2019, 200(3): 327-335.
|
| 19 |
Stortz JA, Cox MC, Hawkins RB, et al. Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study [J].Crit Care, 2020, 24(1): 203.
|
| 20 |
Kudo D, Goto T, Uchimido R, et al. Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies [J].Crit Care, 2021, 25(1): 114.
|
| 21 |
Knox DB, Lanspa MJ, Kuttler KG, et al.Phenotypic clusters within sepsis-associated multiple organ dysfunction syndrome [J].Intensive Care Med, 2015, 41(5): 814-822.
|
| 22 |
Seymour CW, Kennedy JN, Wang S, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis[J].JAMA, 2019, 321(20): 2003.
|
| 23 |
Bhavani SV, Wolfe KS, Hrusch CL, et al. Temperature trajectory subphenotypes correlate with immune responses in patients with sepsis[J].Crit Care Med, 2020, 48(11): 1645-1653.
|
| 24 |
Maslove DM, Tang B, Shankar-Hari M, et al. Redefining critical illness [J].Nat Med, 2022, 28(6): 1141-1148.
|
| 25 |
Wong HR, Cvijanovich NZ, Allen GL, et al. Validation of a gene expression-based subclassification strategy for pediatric septic shock[J].Crit Care Med, 2011, 39(11): 2511-2517.
|
| 26 |
Davenport EE, Burnham KL, Radhakrishnan J, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study [J].Lancet Respir Med, 2016, 4(4): 259-271.
|
| 27 |
Burnham KL, Davenport EE, Radhakrishnan J, et al. Shared and distinct aspects of the sepsis transcriptomic response to fecal peritonitis and pneumonia [J].Am J Respir Crit Care Med, 2017, 196(3): 328-339.
|
| 28 |
Scicluna BP, Van Vught LA, Zwinderman AH, et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study [J].Lancet Respir Med, 2017, 5(10): 816-826.
|
| 29 |
Van Der Poll T, Shankar-Hari M, Wiersinga WJ, et al. The immunology of sepsis [J].Immunity, 2021, 54(11): 2450-2464.
|
| 30 |
Sweeney TE, Azad TD, Donato M, et al. Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters [J].Crit Care Med, 2018, 46(6): 915-925.
|
| 31 |
Baghela A, Pena OM, Lee AH, et al. Predicting sepsis severity at first clinical presentation: the role of endotypes and mechanistic signatures[J].eBioMedicine, 2022, 75: 103776.
|
| 32 |
Sweeney TE, Perumal TM, Henao R, et al. A community approach to mortality prediction in sepsis via gene expression analysis [J].Nat Commun, 2018, 9(1): 694.
|
| 33 |
Brakenridge SC, Chen U-I, Loftus T, et al. Evaluation of a multivalent transcriptomic metric for diagnosing surgical sepsis and estimating mortality among critically ill patients [J].JAMA Netw Open, 2022,5(7): e2221520.
|
| 34 |
Gravrand V, Mellot F, Ackermann F, et al. Stratification of COVID-19 severity using SeptiCyte RAPID, a novel host immune response test [J].Viruses 2023, 15(2): 419.
|
| 35 |
Bodinier M, Monneret G, Casimir M, et al. Identification of a subgroup of critically ill patients with high risk of intensive care unitacquired infections and poor clinical course using a transcriptomic score [J].Crit Care, 2023, 27(1): 158.
|
| 36 |
Liu W, Geng F, Yu L.Long non-coding RNA MALAT1/microRNA 125a axis presents excellent value in discriminating sepsis patients and exhibits positive association with general disease severity, organ injury, inflammation level, and mortality in sepsis patients [J].J Clin Lab Anal, 2020, 34(6): e23222.
|
| 37 |
He F, Zhang C, Huang Q.Long noncoding RNA nuclear enriched abundant transcript 1/miRNA-124 axis correlates with increased disease risk, elevated inflammation, deteriorative disease condition,and predicts decreased survival of sepsis [J].Medicine, 2019, 98(32):e16470.
|
| 38 |
Na L, Ding H, Xing E, Gao J, et al. Lnc-MEG3 acts as a potential biomarker for predicting increased disease risk, systemic inflammation,disease severity, and poor prognosis of sepsis via interacting with miR-21 [J].J Clin Lab Anal, 2020, 34(4): e23123.
|
| 39 |
Stanski NL, Wong HR.Prognostic and predictive enrichment in sepsis[J].Nat Rev Nephrol, 2020, 16(1): 20-31.
|
| 40 |
Antcliffe DB, Burnham KL, Al-Beidh F, et al. Transcriptomic signatures in sepsis and a differential response to steroids.From the VANISH randomized trial [J].Am J Respir Crit Care Med, 2019,199(8): 980-986.
|
| 41 |
Wong HR, Cvijanovich NZ, Anas N, et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock [J].Am J Respir Crit Care Med, 2015, 191(3): 309-315.
|
| 42 |
Calfee CS, Delucchi KL, Sinha P, et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin:secondary analysis of a randomised controlled trial [J].Lancet Respir Med, 2018, 6(9): 691-698.
|